BC3 TECHNOLOGIES

Form 483 issued November 26, 2024 · Baltimore, Maryland

Inspection
Nov 22 – Nov 26, 2024
Investigator
Christina D. Mello
Observations
8
Pages
5
FEI number
3026322855

In short: On November 26, 2024, FDA issued a Form 483 with 8 observations to BC3 TECHNOLOGIES in Baltimore, Maryland (FEI 3026322855) after an inspection that ran Nov 22 – Nov 26, 2024. The investigator was Christina D. Mello. Most observations concern production & process controls and cAPA; the most-cited regulation is 21 CFR 820.198 (complaint files).

At a glance

Production & process controls and capa account for 6 of 8 observations.

Production & process controls3
CAPA3
Design controls2

What FDA observed

Preview: the opening words of each observation
  1. 01

    Device packaging and/or shipping containers are not designed and constructed to protect the device from alteration…

  2. 02

    Records of complaint investigations are not maintained by…

  3. 03

    Requirements that must be met by suppliers have…

  4. 04

    Design output was not…

4 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at BC3 TECHNOLOGIES?

FDA listed 8 observations on this Form 483, mostly about production & process controls, cAPA and design controls. The most-cited regulation is 21 CFR 820.198 (complaint files). The opening words of each observation are shown on this page.

Who inspected BC3 TECHNOLOGIES?

Christina D. Mello is named on this Form 483, for the inspection of Nov 22 – Nov 26, 2024. Each investigator has a profile showing what they cite most.

When was BC3 TECHNOLOGIES inspected by FDA?

The inspection ran Nov 22 – Nov 26, 2024, and the Form 483 is dated November 26, 2024.

How do I get the full Form 483 for BC3 TECHNOLOGIES?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free